Kathryn J Collier - Net Worth and Insider Trading
Kathryn J Collier Net Worth
The estimated net worth of Kathryn J Collier is at least $10,784 dollars as of 2024-12-27. Kathryn J Collier is the Director of Regulus Therapeutics Inc and owns about 6,740 shares of Regulus Therapeutics Inc (RGLS) stock worth over $10,784. Details can be seen in Kathryn J Collier's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kathryn J Collier has not made any transactions after 2024-07-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kathryn J Collier
Kathryn J Collier Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kathryn J Collier owns 1 companies in total, including Regulus Therapeutics Inc (RGLS) .
Click here to see the complete history of Kathryn J Collier’s form 4 insider trades.
Insider Ownership Summary of Kathryn J Collier
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RGLS | Regulus Therapeutics Inc | 2024-07-25 | director |
Kathryn J Collier Latest Holdings Summary
Kathryn J Collier currently owns a total of 1 stock. Kathryn J Collier owns 6,740 shares of Regulus Therapeutics Inc (RGLS) as of July 25, 2024, with a value of $10,784.
Latest Holdings of Kathryn J Collier
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RGLS | Regulus Therapeutics Inc | 2024-07-25 | 6,740 | 1.60 | 10,784 |
Holding Weightings of Kathryn J Collier
Kathryn J Collier Form 4 Trading Tracker
According to the SEC Form 4 filings, Kathryn J Collier has made a total of 1 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Regulus Therapeutics Inc is the acquisition of 4,000 shares on July 25, 2024, which cost Kathryn J Collier around $7,280.
Insider Trading History of Kathryn J Collier
- 1
Kathryn J Collier Trading Performance
GuruFocus tracks the stock performance after each of Kathryn J Collier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kathryn J Collier is -24.75%. GuruFocus also compares Kathryn J Collier's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kathryn J Collier within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kathryn J Collier's insider trading performs compared to the benchmark.
Performance of Kathryn J Collier
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.41 | | | | | |
| Relative Return to S&P 500(%) | -0.1 | | | | | |
Kathryn J Collier Ownership Network
Kathryn J Collier Owned Company Details
What does Regulus Therapeutics Inc do?
Who are the key executives at Regulus Therapeutics Inc?
Kathryn J Collier is the director of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Sr. VP & General Counsel Christopher Ray Aker , Chief Operating Officer Joseph P Hagan , and Chief Financial Officer Crispina Calsada .
Regulus Therapeutics Inc (RGLS) Insider Trades Summary
Over the past 18 months, Kathryn J Collier made 1 insider transaction in Regulus Therapeutics Inc (RGLS) with a net purchase of 4,000. Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Christopher Ray Aker , and a net sale of 5,468 shares made by Crispina Calsada .
In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 21,516 shares.
Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regulus Therapeutics Inc Insider Transactions
Kathryn J Collier Mailing Address
Above is the net worth, insider trading, and ownership report for Kathryn J Collier. You might contact Kathryn J Collier via mailing address: C/o Regulus Therapeutics Inc., 10614 Science Center Drive, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
